Abstract:The structures of protein are diverse and closely related to their physiological functions. Elucidating the mechanisms of protein folding and function remains a prominent challenge in biophysics. Intrinsically disordered proteins (IDPs) are a class of proteins lacking an ordered structure and related to a wide range of diseases such as Alzheimer's disease, Parkinson's disease, cancer, and diabetes, leading to the urgent need to develop powerful methods to characterize the interaction between the structure change and physiological function of these proteins. As a sensitive single-molecule approach, the super-confined aerolysin nanopore has been applied in peptide detection. In order to understand the mechanisms of IDPs folding and function, here, a controlled single-molecule interface of aerolysin nanopore was employed to investigate the protein structural ensembles upon interaction with the environment. We selected the Aβ25-35 fragment with similar physiological functions as β-amyloid peptide 42 (Aβ42) that associates with Alzheimer’s disease as an example to clarify its structural changes in aqueous solution in real-time through the aerolysin nanopore. The dynamic conformation change of peptide in solution can be monitored in real-time via the current blockades and duration time. It can be observed that the conformation of Aβ25-35 changed from random coil to β-sheet. This study facilitates the label-free detection of the dynamic structural changes of IDPs at the single-molecule level rather than measuring the average properties of a protein sample, which has the potential to further make a significant contribution to solving the questions concerning the structure and function of IDPs.

Accelerating Protein Aggregation and Amyloid Fibrillation for Rapid Inhibitor Screening

Inhibitor discovery targeting the intermediate structure of β-amyloid peptide on the conformational transition pathway: Implications in the aggregation mechanism of β-amyloid peptide

Screening Carbon Nano Materials for Preventing Amyloid Protein Aggregation by Adopting a Facile Method

Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.

A droplet reactor on a super-hydrophobic surface allows control and characterization of amyloid fibril growth

Acceleration of amyloid fibril formation by multichannel sonochemical reactor

A Rapid Pipeline to Identify Small Molecule Inhibitors of Amyloid Aggregation

An automated microliter-scale high-throughput screening system (MSHTS) for real-time monitoring of protein aggregation using quantum-dot nanoprobes

A rapid in vivo pipeline to identify small molecule inhibitors of amyloid aggregation

Real-Time Monitoring Conformational Changes of a Intrinsically Disordered Protein with Aerolysin Nanopore

Capillary-Flow-Based One-Minute Quantification of Amyloid Proteolysis

A novel method to predict protein aggregations using two-dimensional native protein microfluidic chip electrophoresis

Fluctuations in protein aggregation: Design of preclinical screening for early diagnosis of neurodegenerative disease

Physicochemical Strategies for Inhibition of Amyloid Fibril Formation: an Overview of Recent Advances

Fast Probing Amyloid Polymorphism via Nanopore Translocation

General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity Against Amyloid Β-Protein and Α-Synuclein.

Rapid Generation of Amyloid from Native Proteins in Vitro.

Prediction of fibril formation by early-stage amyloid peptide aggregation

Preparation of True Solutions of Monomeric Amyloidogenic Protein/peptide: A Critical Prerequisite for Aggregation Kinetic Study

Kinetic Studies of Inhibition of the Amyloid Beta (1–42) Aggregation Using a Ferrocene-Tagged Β-Sheet Breaker Peptide

Tuning protein assembly pathways through superfast amyloid-like aggregation